|
US 11,731,978 B2 |
|
| 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator |
| Andrew Mark Griffin, L'lle Bizard (CA); Brian Edward Marron, Ada, MI (US); and Gabriel Martinez Botella, Wayland, MA (US) |
| Assigned to PRAXIS PRECISION MEDICINES, INC., Boston, MA (US) |
| Filed by PRAXIS PRECISION MEDICINES, INC., Boston, MA (US) |
| Filed on Mar. 23, 2022, as Appl. No. 17/702,518. |
| Application 17/702,518 is a continuation of application No. 17/214,343, filed on Mar. 26, 2021. |
| Application 17/214,343 is a continuation of application No. 17/102,586, filed on Nov. 24, 2020, granted, now 11,014,931, issued on May 25, 2021. |
| Application 17/102,586 is a continuation of application No. PCT/US2019/034653, filed on May 30, 2019. |
| Claims priority of provisional application 62/738,508, filed on Sep. 28, 2018. |
| Claims priority of provisional application 62/677,903, filed on May 30, 2018. |
| Prior Publication US 2022/0220118 A1, Jul. 14, 2022 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 31/519 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); A61P 23/00 (2006.01); A61P 25/08 (2006.01) |
